WASHINGTON , Jan. 12, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the...
/Danaher%20Corp_%20logo%20on%20vial-by%20Melnilov%20Dmitriy%20via%20Shutterstock.jpg)
Danaher will release its fourth-quarter earnings later this month, and analysts anticipate bottom-line to remain unchanged year over year.
WASHINGTON , Jan. 5, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare...
1 Profitable Stock to Keep an Eye On and 2 We Ignore
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. Â
WASHINGTON , Dec. 17, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2025 on Wednesday, January...
/Revvity%20Inc_%20logo%20on%20phone%20and%20site%20by-%20T_Schneier%20via%20Shutterstock.jpg)
Revvity has underperformed the Health Care industry over the past year, but analysts are moderately optimistic about the stock’s prospects.
WASHINGTON , Dec. 9, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common...
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. Â
Despite Danaher’s underperformance relative to the healthcare sector, Wall Street analysts remain strongly optimistic about the stock’s prospects.